The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis
Abstract
The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Bone Marker Standards (WG-BMS) has evaluated the clinical potential of bone turnover markers (BTMs) in the prediction of fracture risk and for monitoring treatment. Research evidence suggests that BTMs may provide information on fracture risk independently from BMD, so that fracture risk prediction might be enhanced by their inclusion in assessment algorithms. The potential use of BTMs to predict the response to treatments for osteoporosis in the individual patient is also of great interest. Treatment-induced changes in specific markers account for a substantial proportion of fracture risk reduction. However, there is still a need for stronger evidence on which to base practice in both situations. IOF/IFCC recommends one bone formation marker (serum procollagen type I N propeptide, s-PINP) and one bone resorption marker (serum C-terminal cross-linking telopeptide of type I collagen, s-CTX) to be used as reference markers and measured by standardised assays in observational and intervention studies in order to enlarge the international experience of the application of markers to clinical medicine and to help resolve uncertainties over their clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
(1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90218-e · Cited by 2,874
FRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467
Self-citationA reference standard for the description of osteoporosis
Kanis, J. A., McCloskey, E. V., Johansson, H., Oden, A., Melton, L. J., & Khaltaev, N. (2008) · Bone · doi:10.1016/j.bone.2007.11.001 · Cited by 1,234
Self-citationfor the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Self-citationMarkers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M.-C., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Bréart, G., Meunier, P. J., & Dr. Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 989
Consensus Development Conference: A Cross-Cultural Study
Larsen, J. K., & Rogers, E. M. (1984) · Knowledge · doi:10.1177/107554708400500406 · Cited by 751
Kopera, H., & Ziegler, R. (1989) · Klinische Wochenschrift · doi:10.1007/bf01719785 · Cited by 749
Garnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Osteoporosis: impact on health and economics
Harvey, N., Dennison, E., & Cooper, C. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.260 · Cited by 687
Self-citationRelationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate
Eastell, R., Barton, I., Hannon, R., Chines, A., Garnero, P., & Delmas, P. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1051 · Cited by 588
Self-citationSerum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc, P., Chapuy, M. C., Meunier, P. J., & Delmas, P. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116387 · Cited by 484
Bauer, D. C., Black, D. M., Garnero, P., Hochberg, M., Ott, S., Orloff, J., Thompson, D. E., Ewing, S. K., Delmas, P. D., & for the Fracture Intervention Trial Study Group (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040512 · Cited by 405
Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study
Sornay-Rendu, E., Munoz, F., Garnero, P., Duboeuf, F., & Delmas, P. D. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050609 · Cited by 394
Vergnaud, P., Garnero, P., Meunier, P. J., Bréart, G., Kamihagi, K., & Delmas, P. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3805 · Cited by 389
Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women
Gerdhem, P., Ivaska, K. K., Alatalo, S. L., Halleen, J. M., Hellman, J., Isaksson, A., Pettersson, K., Väänänen, H. K., Åkesson, K., & Obrant, K. J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301244 · Cited by 283
Identification of High‐Risk Individuals for Hip Fracture: A 14‐Year Prospective Study
Nguyen, N. D., Pongchaiyakul, C., Center, J. R., Eisman, J. A., & Nguyen, T. V. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050520 · Cited by 231
Arlot, M., Meunier, P. J., Boivin, G., Haddock, L., Tamayo, J., Correa-Rotter, R., Jasqui, S., Donley, D. W., Dalsky, G. P., Martin, J. S., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050309 · Cited by 226
Szulc, P., & Delmas, P. D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0660-9 · Cited by 220
Sarkar, S., Reginster, J.-Y., Crans, G. G., Diez-Perez, A., Pinette, K. V., & Delmas, P. D. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301243 · Cited by 210
Serum Bone Alkaline Phosphatase and Calcaneus Bone Density Predict Fractures: A Prospective Study
Ross, P. D., Kress, B. C., Parson, R. E., Wasnich, R. D., Armour, K. A., & Mizrahi, I. A. (2000) · Osteoporosis International · doi:10.1007/s001980050009 · Cited by 207
Vergnaud, P. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.719 · Cited by 202
Luukinen, H., Käkönen, S.-M., Pettersson, K., Koski, K., Laippala, P., Lövgren, T., Kivelä, S.-L., & Väänänen, H. K. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2473 · Cited by 197
van Daele, P. L. A., Seibel, M. J., Burger, H., Hofman, A., Grobbee, D. E., van Leeuwen, J. P. T. M., Birkenhager, J. C., & Pols, H. A. P. (1996) · BMJ · doi:10.1136/bmj.312.7029.482 · Cited by 194
Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study
Meier, C., Nguyen, T. V., Center, J. R., Seibel, M. J., & Eisman, J. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041207 · Cited by 169
Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:
Chapurlat, R. D., Garnero, P., Brárt, G., Meunier, P. J., & Delmas, P. D. (2000) · Bone · doi:10.1016/s8756-3282(00)00325-2 · Cited by 159
Ivaska, K. K., Gerdhem, P., Väänänen, H. K., Åkesson, K., & Obrant, K. J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091006 · Cited by 150
Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study
Bauer, D. C., Garnero, P., Harrison, S. L., Cauley, J. A., Eastell, R., Ensrud, K. E., & ORWOLL, E. S. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090526 · Cited by 147
Self-citationPredictors of Fractures in Elderly Women
Tromp, A. M., Ooms, M., Popp‐Snijders, C., Roos, J. C., & Lips, P. T. A. M. (2000) · Osteoporosis International · doi:10.1007/pl00004174 · Cited by 139
Melton, L. J., Crowson, C. S., O’Fallon, W. M., Wahner, H. W., & Riggs, B. L. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.312 · Cited by 138
Garnero, P., Cloos, P. A., Sornay‐Rendu, E., Qvist, P., & Delmas, P. D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.826 · Cited by 129
Dargent‐Molina, P., Douchin, M. N., Cormier, C., Meunier, P. J., & Bréart, G. (2002) · Osteoporosis International · doi:10.1007/s001980200078 · Cited by 125
Delmas, P. D., Munoz, F., Black, D. M., Cosman, F., Boonen, S., Watts, N. B., Kendler, D. L., Eriksen, E. F., Mesenbrink, P. G., & Eastell, R. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090310 · Cited by 123
Self-citationReginster, J., Sarkar, S., Zegels, B., Henrotin, Y. E., Bruyère, O., Agnusdei, D., & Collette, J. (2003) · Bone · doi:10.1016/j.bone.2003.10.004 · Cited by 115
Interlaboratory Variation of Biochemical Markers of Bone Turnover
Seibel, M. J., Lang, M., & Geilenkeuser, W. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.8.1443 · Cited by 110
Åkesson, K. S., Ljunghall, S., Jönsson, B., Sernbo, I., Johnell, O., Gärdsell, P., & Obrant, K. J. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101127 · Cited by 110
Bone markers : biochemical and clinical perspectives
Eastell, R. (2001) · Martin Dunitz eBooks · Cited by 55
Self-citationDobnig, H., Piswanger-Sölkner, J. C., Obermayer-Pietsch, B. M., Tiran, A., Groselj‐Strele, A., Maier, E., Maritschnegg, P., Riedmüller, G., Brueck, C. C., & Fahrleitner‐Pammer, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2079 · Cited by 53
Bruyère, O., Collette, J., Delmas, P. D., Rouillon, A., Roux, C., Seidel, L., Richy, F. F., & Reginster, J. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00042-2 · Cited by 53
Cited by
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
Self-citationUse of bone turnover markers in postmenopausal osteoporosis
Eastell, R., & Szulc, P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30184-5 · Cited by 594
Self-citationPathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Bone turnover markers: use in osteoporosis
Naylor, K., & Eastell, R. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.86 · Cited by 262
Self-citationHe, J., Xu, S., Zhang, B., Xiao, C., Chen, Z., Si, F., Fu, J., Lin, X., Zheng, G., Yu, G., et al. (2020) · Aging · doi:10.18632/aging.103168 · Cited by 258
Metadata
- Authors
- Vasikaran, S., Cooper, C., Eastell, R., Griesmacher, A., Morris, H. A., Trenti, T., & Kanis, J. A.
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2011-05-24
- Volume
- 49
- Issue
- 8
- Pages
- 1271-1274
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2165275292
- Cited by
- 380
- References
- 38
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.